Mechanistically, ZDHHC3 could enhance tumor progression by increasing the level of palmitoylated modifications of PD-L1 in MC38 tumor models and support breast tumor progression by regulating cellular oxidative stress and senescence. Here, ZDHHC3 is linked to breast neoplasm.